Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E Kotova
Observed names:
E. Kotova,
Ekaterina V. Kotova
Institution:
National Medical Research Center for Hematology
Observed institutions:
National Medical Research Center for Hematology,
National Medical and Surgical Center named after N.I. Pirogov
ORCID:
0009-0003-2140-352X
Observed ORCID:
0009-0003-2140-352X
OpenAlex ID:
A5002471048
ALL-239: IKZF1 Deletions Predict Refractory Disease and Poor Survival in De Novo Ph-Negative B-Cell Acute Lymphoblastic Leukemia: Data From the RALL-2016 Study
2025
·
Olga Aleshina
, E Kotova
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
POSTER: ALL-239 IKZF1 Deletions Predict Refractory Disease and Poor Survival in De Novo Ph-Negative B-Cell Acute Lymphoblastic Leukemia: Data From the RALL-2016 Study
2025
·
Olga Aleshina
, E Kotova
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study
2024
·
Ilya A. Pokataev
, Daniil L. Stroyakovskiy
, et al.
·
Journal of Modern Oncology
PDF
ALL-056 Late Intensification With Autologous HSCT After Non-Myeloablative CEAM Conditioning Can't Improve Results of Therapy in Adults With T-Cell Acute Lymphoblastic Leukemia (ALL) Treated by Non-Intensive Protocol: Data of the Multicentral Prospective Randomized RALL Study
2022
·
Olga Aleshina
, I. Galtseva
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Poster: ALL-056 Late Intensification With Autologous HSCT After Non-Myeloablative CEAM Conditioning Can't Improve Results of Therapy in Adults With T-Cell Acute Lymphoblastic Leukemia (ALL) Treated by Non-Intensive Protocol: Data of the Multicentral Prospective Randomized RALL Study
2022
·
Olga Aleshina
, I. Galtseva
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
5
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type